Skip to main content
Caplight Logo









Bakar BioLabs

Bakar BioLabs

Berkeley, Californiabakarlabs.org

Overview

Bakar BioLabs is a life science-focused incubator for startups, operated in partnership by UC Berkeley and QB3.

Year Founded

2022

Portfolio Companies

1

Investments

Bakar BioLabs investments
CompanyDateStageLead
ARIZ Precision MedicineJul 2024GrantCo-investor

Key People

David Schaffer

Director

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Bakar BioLabs based?

Bakar BioLabs is headquartered in Berkeley, California, United States.

When was Bakar BioLabs founded?

Bakar BioLabs was founded in 2022.

How many portfolio companies does Bakar BioLabs have?

Bakar BioLabs has 1 portfolio company in Caplight's dataset.

What are some companies in Bakar BioLabs's portfolio?

Portfolio companies visible on Caplight include ARIZ Precision Medicine.

What was Bakar BioLabs's most recent investment shown here?

Bakar BioLabs's most recent investment in this portfolio sample was in ARIZ Precision Medicine in 2024.

What sectors does Bakar BioLabs focus on?

Bakar BioLabs focuses on Healthcare & Life Sciences.

What company stages does Bakar BioLabs focus on?

Stage focus information for Bakar BioLabs is not publicly available.

Firmographic Details

HeadquartersBerkeley, California
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?